- Home
- ARMP vs RLGT Comparison
ARMP vs RLGT Comparison
Compare ARMP & RLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARMP | RLGT |
|---|---|---|
| Founded | N/A | 2001 |
| Country | US | US |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil Refining/Marketing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 296.7M | 291.6M |
| IPO Year | 1996 | 2006 |
Fundamental Metrics
Financial Performance| Metric | ARMP | RLGT |
|---|---|---|
| Price | $8.20 | $7.70 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $12.00 | $8.00 |
| AVG Volume (30 Days) | 35.3K | ★ 209.7K |
| Earning Date | 02-24-2026 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 53.40 | ★ 118.75 |
| EPS | N/A | ★ 0.14 |
| Revenue | N/A | ★ $902,696,000.00 |
| Revenue This Year | N/A | $2.13 |
| Revenue Next Year | N/A | $5.18 |
| P/E Ratio | ★ N/A | $26.59 |
| Revenue Growth | N/A | ★ 12.49 |
| 52 Week Low | $0.90 | $5.44 |
| 52 Week High | $13.75 | $8.50 |
Technical Indicators
Market Signals| Indicator | ARMP | RLGT |
|---|---|---|
| Relative Strength Index (RSI) | 61.60 | 60.81 |
| Support Level | $7.75 | $7.11 |
| Resistance Level | $8.36 | $8.50 |
| Average True Range (ATR) | 0.59 | 0.37 |
| MACD | 0.05 | 0.05 |
| Stochastic Oscillator | 85.53 | 59.09 |
Price Performance
Historical ComparisonAbout ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
About RLGT Radiant Logistics Inc.
Radiant Logistics Inc operates as a third-party logistics company, providing multi-modal transportation and logistics services to customers based in the United States and Canada. The company offers domestic and international air and ocean freight forwarding services and freight brokerage services including truckload services, less-than-truckload (LTL) services, and intermodal services. It has two geographic operating segments: the United States and Canada. Maximum revenue is generated in the United States.